FDA looks to accelerate plasma therapies for coronavirus 06-Apr-2020 By Ben Hargreaves US FDA looks to coordinate and speed up the development of blood-derived therapies to treat patients with COVID-19.
Daiichi pays $225m to access gene therapy production platform 06-Apr-2020 By Ben Hargreaves Daiichi partners with Ultragenyx to utilize its HeLa producer cell line platform for commercial-scale gene therapy production.
Arch Venture raises $1.4bn fund to spur ‘healthcare revolution’ 02-Apr-2020 By Ben Hargreaves Arch Venture announces that it raised the sum across two funds, with the capital earmarked for early stage biotechs.
Avectas partners with Vycellix to speed cell therapy production 31-Mar-2020 By Ben Hargreaves The partners will combine expertise to progress the novel RNA immunomodulator, VY-M.
Latest industry developments against COVID-19 30-Mar-2020 By Ben Hargreaves In the face of the threat from the novel coronavirus, industry momentum is gathering to produce a solution.
J&J chooses lead coronavirus candidate, sets up manufacturing for 1 billion doses 30-Mar-2020 By Ben Hargreaves The company provides update on its coronavirus plans, which includes $1bn in funding to research and expected Phase I trial commencement date.
Takeda taps Evox for exosome therapeutics 30-Mar-2020 By Ben Hargreaves The partners will focus on developing five potential exosome treatment for rare diseases.
Gates Foundation in ‘unprecedented’ coronavirus partnership with industry 26-Mar-2020 By Ben Hargreaves ‘Collective action is critical,’ says Novartis CEO on industry partnership with Gates Foundation to accelerate treatments for COVID-19.
Astellas and CytomX team up to target solid tumors with T-cells 26-Mar-2020 By Ben Hargreaves The two partners will work to develop clinical candidates for the treatment of cancer.
Roche ups Actemra production anticipating increased demand 25-Mar-2020 By Vassia Barba Roche looks to maximize production of its arthritis treatment as the drug enters late-stage trials to evaluate its effectiveness against COVID-19.
CGTC in ‘third phase’ expansion of cell and gene manufacturing site 20-Mar-2020 By Ben Hargreaves CGTC will add seven laboratories to its manufacture site in the UK, with most of the work taking place off-site.
Roche’s treatment for coronavirus enters Phase III 19-Mar-2020 By Ben Hargreaves Roche looks to repurpose its arthritis medicine for use against the coronavirus, after China previously endorsed its use.
Moderna’s coronavirus vaccine enters Phase I, ‘accelerates’ manufacturing capabilities 17-Mar-2020 By Ben Hargreaves A vaccine for the virus has reached first-in-man stage, as companies race to find a solution to the global crisis.
Pipeline of cell and gene therapies expands by 25% 16-Mar-2020 By Ben Hargreaves During the course of just one year, the US pipeline of cell and gene therapies has developed rapidly, as approvals increase.
Gates Foundation, Wellcome and Mastercard partner to combat coronavirus 12-Mar-2020 By Ben Hargreaves The three organizations set up the COVID-19 Therapeutics Accelerator, backing the initiative with $125m.
